Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a South Florida-based clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce that it has tapped Harry L. Leider, MD, MBA as its…